| 000 | 01841 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517084132.0 | ||
| 264 | 0 | _c20170630 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1582-4934 | ||
| 024 | 7 |
_a10.1111/jcmm.12811 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHung, Ming-Szu | |
| 245 | 0 | 0 |
_aKnockdown of cullin 4A inhibits growth and increases chemosensitivity in lung cancer cells. _h[electronic resource] |
| 260 |
_bJournal of cellular and molecular medicine _c07 2016 |
||
| 300 |
_a1295-306 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCullin Proteins _xmetabolism |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p21 _xmetabolism |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Knockdown Techniques |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aLung Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xmetabolism |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xmetabolism |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aChen, I-Chuan | |
| 700 | 1 | _aYou, Liang | |
| 700 | 1 | _aJablons, David M | |
| 700 | 1 | _aLi, Ya-Chin | |
| 700 | 1 | _aMao, Jian-Hua | |
| 700 | 1 | _aXu, Zhidong | |
| 700 | 1 | _aLung, Jr-Hau | |
| 700 | 1 | _aYang, Cheng-Ta | |
| 700 | 1 | _aLiu, Shih-Tung | |
| 773 | 0 |
_tJournal of cellular and molecular medicine _gvol. 20 _gno. 7 _gp. 1295-306 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jcmm.12811 _zAvailable from publisher's website |
| 999 |
_c25819944 _d25819944 |
||